DK0741741T3 - Modificerede oligonucleotider - Google Patents

Modificerede oligonucleotider

Info

Publication number
DK0741741T3
DK0741741T3 DK95906958T DK95906958T DK0741741T3 DK 0741741 T3 DK0741741 T3 DK 0741741T3 DK 95906958 T DK95906958 T DK 95906958T DK 95906958 T DK95906958 T DK 95906958T DK 0741741 T3 DK0741741 T3 DK 0741741T3
Authority
DK
Denmark
Prior art keywords
pct
nucleotides
sec
modified oligonucleotides
date
Prior art date
Application number
DK95906958T
Other languages
English (en)
Inventor
Catherine Lesueur
Mesmaeker Alain De
Adrian Waldner
Jacques Lebreton
Marc-Olivier Bevierre
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9401446A external-priority patent/GB9401446D0/en
Priority claimed from GB9412526A external-priority patent/GB9412526D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0741741T3 publication Critical patent/DK0741741T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK95906958T 1994-01-26 1995-01-17 Modificerede oligonucleotider DK0741741T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9401446A GB9401446D0 (en) 1994-01-26 1994-01-26 Modified oligonucleotides
GB9412526A GB9412526D0 (en) 1994-06-22 1994-06-22 Modified oligonucleotides
PCT/EP1995/000156 WO1995020597A1 (en) 1994-01-26 1995-01-17 Modified oligonucleotides

Publications (1)

Publication Number Publication Date
DK0741741T3 true DK0741741T3 (da) 2002-12-23

Family

ID=26304218

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95906958T DK0741741T3 (da) 1994-01-26 1995-01-17 Modificerede oligonucleotider

Country Status (13)

Country Link
US (1) US6066447A (da)
EP (1) EP0741741B1 (da)
JP (1) JPH09508134A (da)
AT (1) ATE222921T1 (da)
AU (1) AU697134B2 (da)
CA (1) CA2180727A1 (da)
DE (1) DE69527942T2 (da)
DK (1) DK0741741T3 (da)
FI (1) FI116677B (da)
HU (1) HU220423B (da)
IL (1) IL112424A0 (da)
NO (1) NO316902B1 (da)
WO (1) WO1995020597A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9408310A (pt) * 1993-12-13 1997-08-26 Procter & Gamble Composição de amaciamento de tecido concentrada líquida de viscosidade estável
US6166197A (en) * 1995-03-06 2000-12-26 Isis Pharmaceuticals, Inc. Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions
DE69636160D1 (de) 1995-03-06 2006-06-29 Isis Pharmaceuticals Inc Verfahren zur synthese von 2'-0-substituierten pyrimidinen und oligomere davon
WO1997014709A1 (en) * 1995-10-13 1997-04-24 F. Hoffmann-La Roche Ag Antisense oligomers
US5808035A (en) * 1995-12-08 1998-09-15 Usher; David A. Protected nucleoside and method for its synthesis
AU3340797A (en) * 1996-06-28 1998-01-21 Novartis Ag Modified oligonucleotides
US6143743A (en) 1997-07-03 2000-11-07 Dupont Pharmaceuticals Company Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
US6878716B1 (en) 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
AR020590A1 (es) 1998-06-02 2002-05-22 Cadus Pharmaceutical Corp 7-diazapurina-n-6 sustituida, un metodo para su preparacion, composiciones farmaceuticas que la comprenden
US6686366B1 (en) 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
US6680322B2 (en) 1999-12-02 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6664252B2 (en) 1999-12-02 2003-12-16 Osi Pharmaceuticals, Inc. 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
US7160890B2 (en) 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6673802B2 (en) 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
AU2002360436A1 (en) 2001-11-30 2003-06-17 Osi Pharmaceuticals, Inc. 2-aryl pyrrologpyrimidines for a1 and a3 receptors
US6916804B2 (en) 2001-12-20 2005-07-12 Osi Pharmaceuticals, Inc. Pyrimidine A2b selective antagonist compounds, their synthesis and use
DE60236458D1 (de) 2001-12-20 2010-07-01 Osi Pharm Inc Pyrrolopyrimidin a2b selektive antagonistische verbindungen, deren synthese und verwendung
KR100649352B1 (ko) * 2005-04-30 2006-11-27 주식회사 하이닉스반도체 반도체소자의 제조 방법
US7820810B2 (en) 2007-03-19 2010-10-26 Isis Pharmaceuticals, Inc. Process for the synthesis of 2′-O-substituted purine nulceosides
CA3033133C (en) 2009-03-25 2021-11-09 The Board Of Regents Of The University Of Texas System Compositions for stimulation of mammalian innate immune resistance to pathogens
WO2016044839A2 (en) 2014-09-19 2016-03-24 The Board Of Regents Of The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
MX2018001315A (es) * 2015-07-30 2018-08-15 Horizon Orphan Llc Inhibidores de fucosidasa.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
EP0266099A3 (en) * 1986-10-28 1990-09-19 The Johns Hopkins University Oligonucleoside alkyl or arylphosphonate derivatives capable of crosslinking with or cleaving nucleic acids
EP0402402B1 (en) * 1988-02-26 1995-12-27 Worcester Foundation For Biomedical Research, Inc. Inhibition of htlv-iii by exogenous oligonucleotides
EP0942000B1 (en) * 1989-10-24 2004-06-23 Isis Pharmaceuticals, Inc. 2'-Modified oligonucleotides
US5378825A (en) * 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
ES2083593T3 (es) * 1990-08-03 1996-04-16 Sterling Winthrop Inc Compuestos y metodos para inhibir la expresion de genes.
WO1992005186A1 (en) * 1990-09-20 1992-04-02 Gilead Sciences Modified internucleoside linkages

Also Published As

Publication number Publication date
FI116677B (fi) 2006-01-31
AU697134B2 (en) 1998-09-24
DE69527942T2 (de) 2003-03-27
AU1534795A (en) 1995-08-15
FI962980A (fi) 1996-07-26
HUT75704A (en) 1997-05-28
EP0741741B1 (en) 2002-08-28
US6066447A (en) 2000-05-23
WO1995020597A1 (en) 1995-08-03
FI962980A0 (fi) 1996-07-26
EP0741741A1 (en) 1996-11-13
NO963092L (no) 1996-09-16
ATE222921T1 (de) 2002-09-15
NO316902B1 (no) 2004-06-21
IL112424A0 (en) 1995-03-30
JPH09508134A (ja) 1997-08-19
DE69527942D1 (de) 2002-10-02
NO963092D0 (no) 1996-07-24
HU220423B (hu) 2002-01-28
CA2180727A1 (en) 1995-08-03
HU9602040D0 (en) 1996-09-30

Similar Documents

Publication Publication Date Title
ATE222921T1 (de) Modifizierte oligonukleotide
CA2202280A1 (en) Sugar modified nucleosides and their use for synthesis of oligonucleotides
DE69403642D1 (de) 7-deazapurin modifizierte oligonukleotide
DK0712860T3 (da) Fremgangsmåde til oprensning og isolation af 2'-deoxy-2',2'-diflournukleosider
DE69838449D1 (de) Aminooxy-modifizierte oligonukleotide
DE3854297D1 (de) Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung.
ES2061416T1 (es) Ribocimas modificadas.
FI913236A (fi) 9-purinylfosfonsyraderivat.
NZ332834A (en) Glycosaminoglycan-related carbohydrate derivatives ( 5 saccharide groups ) having 4 to 6 sulphate groups
DE3671896D1 (de) Herstellung von cytosin-nukleosiden.
DK630589D0 (da) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning
FR2738827B1 (fr) Detection des enterobacteries
BR9801143A (pt) Copolìmeros de bloco de siloxano inovativos com espaçamento rìgidos e uso dos mesmos.
ES2128426T3 (es) Retinoides acuosolubles.
AU2739797A (en) (in situ) preparation of nucleoside phosphoramidites and their use in synthesis of oligonucleotides
NO962848D0 (no) Monohydrat av (E)-2'-deoksy-2'-(fluormetylen)cytidin
DK0611373T3 (da) Oligo-2-desoxynukleotider og deres anvendelse som lægemidler med antiviral virkning.